[Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
Antibacterial activity of cefmenoxime (CMX) against clinically isolated organisms was examined in comparison with that of 4 other antibiotics and concluded as follows: Antibacterial activity of CMX was markedly stronger than those of cefazolin (CEZ), cefmetazole, latamoxef and ampicillin against E. coli, K. pneumoniae, S. marcescens, H. influenzae, P. mirabilis and indole positive Proteus. But the MIC level of CMX against S. aureus was higher than that of CEZ.
D000667:Ampicillin / Q000494:pharmacology; D002437:Cefazolin / Q000494:pharmacology; D015281:Cefmenoxime; D015311:Cefmetazole; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000494:pharmacology; D002513:Cephamycins / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D009070:Moxalactam / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects; D011513:Proteus mirabilis / Q000187:drug effects; D012706:Serratia marcescens / Q000187:drug effects
D002513:Cephamycins; D015311:Cefmetazole; D000667:Ampicillin; D002437:Cefazolin; D015281:Cefmenoxime; D002439:Cefotaxime; D009070:Moxalactam